LP
LEGN icon

LMR Partners’s Legend Biotech LEGN Stock Holding History

LMR Partners’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,600
Closed -$115K – 1415
2024
Q2 		$115K Sell
2,600
-9,800
-79% -$452K ﹤0.01% 890
2024
Q1 		$696K Sell
12,400
-10,600
-46% -$639K 0.01% 724
2023
Q4 		$1.38M Buy
+23,000
New +$1.46M 0.02% 527

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FBIL
First Beijing Investment Ltd Hong Kong $2.32B AUM 8.06% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

LMR Partners's LEGN Position: Q1 2026 in Review

LMR Partners held its Legend Biotech (LEGN) position steady in Q1 2026 at 35,000 shares worth $633K. The position accounts for ﹤0.01% of the portfolio, ranked #1059.

LMR Partners first reported a position in LEGN in Q4 2021 and has held it in 17 quarters since. The position peaked at $6.06M in Q3 2024. 189 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

  • LMR Partners held 35,000 shares of Legend Biotech worth $633K as of Q1 2026.
  • LMR Partners left its Legend Biotech share count unchanged in Q1 2026.
  • Legend Biotech made up ﹤0.01% of LMR Partners's portfolio in Q1 2026, its #1059 holding.
  • LMR Partners first reported a position in Legend Biotech in Q4 2021 and has held it in 17 quarters since.
  • LMR Partners's Legend Biotech position peaked at $6.06M in Q3 2024.
  • 189 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on LMR Partners's 13F filing for Q1 2026, filed 15 May 2026.